TY  - JOUR
AU  - Puerta-García, E
AU  - Urbano-Pérez, D
AU  - Carrasco-Campos, M I
AU  - Pérez-Ramírez, C
AU  - Segura-Pérez, A
AU  - Calleja-Hernández,
AU  - Cañadas-Garre, M
PY  - 2020
DO  - 10.1016/j.suronc.2020.09.016
UR  - http://hdl.handle.net/10668/16386
T2  - Surgical oncology
AB  - ABCB1, DPYD, MHTFR, XRCC1, ERCC1, GSTP1 and UGT1A1 genetic variants affect proteins related to CRC chemotherapy toxicity. A retrospective cohort study was conducted in 194 CRC patients. In first line treatment, DPYD rs17376848 AG genotype was...
LA  - en
KW  - COLORECTAL CANCER
KW  - Chemotherapy TREATMENT
KW  - Polymorphisms
KW  - TOXICITY
KW  - ATP Binding Cassette Transporter, Subfamily B
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - Antineoplastic Agents
KW  - Capecitabine
KW  - Colorectal Neoplasms
KW  - DNA-Binding Proteins
KW  - Dihydrouracil Dehydrogenase (NADP)
KW  - Endonucleases
KW  - Female
KW  - Fluorouracil
KW  - Genotype
KW  - Glutathione S-Transferase pi
KW  - Humans
KW  - Male
KW  - Methylenetetrahydrofolate Reductase (NADPH2)
KW  - Middle Aged
KW  - Oxaliplatin
KW  - Polymorphism, Genetic
KW  - Retrospective Studies
KW  - Spain
KW  - X-ray Repair Cross Complementing Protein 1
TI  - Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma.
TY  - research article
VL  - 35
ER  -